Publish in this journal
Journal Information
Vol. 75. Issue 7.
Pages 576-584 (July 2022)
Not available
Vol. 75. Issue 7.
Pages 576-584 (July 2022)
Original article
Full text access
Lifestyle and cardiovascular mortality in menopausal women: a population-based cohort study
Hábitos de vida y mortalidad cardiovascular de las mujeres menopáusicas: estudio de cohortes de base poblacional
José A. Quesadaa, Vicente Bertomeu-Gonzáleza,b,c, Juan M. Ruiz-Nodara,c,d, Adriana López-Pinedaa,
Corresponding author

Corresponding author: Departamento de Medicina Clínica, Universidad Miguel Hernández de Elche, Ctra. N-332 Alicante-Valencia s/n, 03550 San Juan de Alicante, Alicante, Spain.
, Francisco Sánchez-Ferrera,e
a Grupo de Investigación Cardiovascular (GRINCAVA), Departamento de Medicina Clínica, Universidad Miguel Hernández de Elche, San Juan de Alicante, Alicante, Spain
b Sección de Cardiología, Hospital Universitario de San Juan de Alicante, San Juan de Alicante, Alicante, Spain
c Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares (CIBERCV), Spain
d Servicio de Cardiología, Hospital General Universitario de Alicante, Alicante, Spain
e Departamento de Farmacología, Pediatría y Química Orgánica, Universidad Miguel Hernández de Elche, San Juan de Alicante, Alicante, Spain
This item has received
Article information
Full Text
Download PDF
Figures (1)
Additional material (1)
Introduction and objectives

There are models for cardiovascular risk prediction in the general population, but the prediction of risk in postmenopausal women has not been specifically studied. This study aimed to determine the association of lifestyle habits and chronic diseases with cardiovascular risk in menopausal women, as well as to build a risk scale.


Retrospective population-based cohort study using data from the 2011 National Health Survey of Spain as a data source, Women ≥ 50 years were included. The characteristics that best defined the life habits of the study women were collected, as well as their health status and self-reported medical history at the time of the survey. Follow-up data on all-cause mortality were obtained from participants from 2011 to 2017.


A total of 5953 women ≥ 50 years of age were included, with a mean age of 66.4 ± 11.4 years. The incidence of cardiovascular mortality in the follow-up period was 4%. Vegetable consumption less than 1 time/week (HR, 1.758), smoking (HR, 1.816) or excess hours of sleep (≥ 9h/day, HR, 1.809), or o have main daily activity sitting most of the time (HR, 2.757) were related to cardiovascular mortality. The predictive model presents an honest C-index in test sample of 0.8407 (95%CI, 0.8025-0.8789).


Life habits such as the consumption of vegetables, daily main activity, sleeping hours or smoking are risk factors for cardiovascular mortality of great relevance among menopausal women. A simple 6-year self-reported risk scale with high predictive capacity is provided.

Heart disease risk factors
Cardiovascular disease
Introducción y objetivos

Existen modelos de predicción de riesgo cardiovascular en población general, pero no se ha estudiado de modo específico la predicción del riesgo de las mujeres posmenopáusicas. El objetivo de este estudio es conocer los hábitos de vida y las enfermedades crónicas asociados con mayor riesgo cardiovascular en mujeres menopáusicas, así como construir una escala de riesgo.


Estudio de cohortes retrospectivo de base poblacional cuya fuente de datos es la Encuesta Nacional de Salud de España de 2011. Se incluyó a mujeres de edad ≥ 50 años. Se recogieron las características que mejor definían los hábitos de vida de las mujeres del estudio, así como su estado de salud y los antecedentes médicos declarados por ellas en el momento de la encuesta. Se realizó seguimiento de la mortalidad de las mujeres del estudio desde 2011 hasta 2017.


Se incluyó a 5.953 mujeres con una media de edad de 66,4±11,4 años. La incidencia de mortalidad cardiovascular en el periodo de seguimiento fue del 4%. Se relacionaron con la mortalidad cardiovascular el consumo de verduras menor de 1 vez/semana (HR=1,758), el tabaquismo (HR=1,816) el exceso de horas de sueño (≥ 9 h/día, HR=1,809) o tener actividad principal diaria sentada la mayor parte del tiempo (HR=2,757). El modelo predictivo presenta un estadístico C «sincero» en muestra de prueba de 0,8407 (IC95%, 0,8025-0,8789).


Hábitos de vida como el consumo de verduras, la actividad principal diaria, las horas de sueño o el tabaquismo son factores de riesgo de mortalidad cardiovascular de gran relevancia entre las mujeres menopáusicas. Se aporta una sencilla escala de riesgo autorreferida a 6 años con elevada capacidad predictiva.

Palabras clave:
Factores de riesgo cardiovascular
Enfermedad cardiovascular
Full Text

Cardiovascular disease (CVD) is the leading cause of morbidity and mortality worldwide.1 Guidelines exist for the primary prevention of CVD and their aim is to establish recommendations to reduce risk,2 but there are considerable differences between men and women.3 According to data from the United States for the period 2013 to 2016, premenopausal women had lower rates of CVD than men of the same age, whereas postmenopausal women had higher rates.4 The difference was even greater for women in early menopause.5 Differences in health care are also a cause for concern. Because CVD presents differently in women, it is often diagnosed and treated later than in men, increasing the risk of poor outcomes.6

Many CV risk prediction models exist for the general population.7 While most do not account for the differential characteristics of women, a number of models in the United States have included female-specific risk factors.8,9

It has been shown that women with diabetes have a 58% greater risk of coronary heart disease and a 13% greater risk of all-cause mortality than men with the same condition.10 Similarly, hyperlipidemia appears to be associated with an increased CVD risk in postmenopausal women.11 No clear associations, however, have been identified for other classic risk factors such as smoking and alcohol consumption in this population.12 Obesity13 and sedentary behavior may increase the risk of CVD and hospitalization for heart failure in women after menopause.14

The aim of this study was to determine the influence of lifestyle habits and chronic disease on increased CV risk in a representative sample of women of menopausal age from a national health survey in Spain and to use our findings to build an easy-to-apply risk scale.


We performed a population-based retrospective observational cohort study using data from the 2011 National Spanish Health Survey (ENSE11) conducted by the National Statistics Institute (INE) between July 2011 and June 2012. This survey is representative of all residents aged over 18 years in Spain and the sample was obtained using a complex stratified 3-stage design. The study was conducted in accordance with the principles of the Declaration of Helsinki and was approved by the Office of Responsible Research at Universidad Miguel Hernández in Elche, Alicante.

We included women aged 50 years and older and excluded those with missing data for any of the study variables. Information was collected on sociodemographic variables, the population characteristics that best defined the lifestyle habits of the women included, self-reported health status and medical history at the time of the survey, and mortality data for a 6-year follow-up period (2011-2017). Mortality data were provided by the INE, which used probabilistic record linkage to match data from the ENSE11 to causes of death from the national death registry. We distinguished between mortality due to CVD (deaths due to diseases of the circulatory system [codes 100-199 in the 10th revision of the International Classification of Diseases]) and mortality due to other causes.

The following exposure variables were extracted from the ENSE11:

  • Sociodemographic variables: age, place of residence (autonomous community), social class based on occupation of reference person,15 country of birth, civil status, level of education, and net monthly household income.

  • Lifestyle variables: smoking, exposure to environmental smoke, alcohol consumption, hours of daily sleep, type of physical activity in main daily activity, frequency of physical activity in leisure time, dental hygiene, and consumption of fruit, vegetables, pulses, dairy products, sweet products, and fast food.

  • Health status: body mass index (BMI), use of a hearing aid, chronic or long-term diseases, current or past history of hypertension, myocardial infarction, other heart diseases, varicose veins, osteoarthritis, chronic neck pain, chronic lower back pain, allergies, asthma, chronic obstructive pulmonary disease, diabetes mellitus, stomach ulcer, urinary incontinence, high cholesterol, cataracts, chronic skin diseases, constipation, cirrhosis, migraine, hemorrhoids, osteoporosis, thyroid problems, stroke, malignant tumor, chronic depression, chronic anxiety, permanent injury due to an accident, or mental health.

  • Self-reported health and health-related quality of life: self-perceived health in the past 12 months, self-rated health on the 5-level EQ-5D (EQ-5D-5L) visual analog scale (VAS), and limitations in activities of daily living due to health problems in the past 6 months or longer.

  • Use of health services: admission to hospital in the past 12 months, admission to a day hospital in the past 12 months, emergency care in the past 12 months, primary care visit in the past month, specialist consultation in the past month, physical therapy in the past year, psychology consultation in the past year, radiography in the past year, computed tomography in the past year, ultrasound in the past year, magnetic resonance imaging in the past year, and vaccination in the last flu vaccination campaign.

The items within each category are shown in the methods section of the supplementary data.

Statistical analysis

Frequencies of all qualitative variables were calculated for the descriptive analysis. Factors associated with CV mortality were analyzed using contingency tables and the chi-square test. To estimate the magnitude of CV risk over 6 years, we built multivariate Cox models that adjusted for competing risks between CV mortality and mortality due to other causes using the approach of Putter et al.16 applied by Moore.17 Hazard ratios (HRs) with 95% confidence intervals (95%CIs) were calculated. The most parsimonious model was selected using the Akaike Information Criterion with forward stepwise selection. The proportional hazards assumption of the model was tested, as was goodness of fit using the likelihood ratio test (LRT). The predictive performance of the model was tested using the C index and 95%CI. The model was built using a random sample of 70% of the original sample and validated using the remaining 30%. The results of the optimal model were used to build a 6-year CV mortality risk scale following the approach described by Sullivan et al.18 To obtain a representative sample of the Spanish population within the complex sampling approach, we applied the raising factor of the sample divided by its mean as a weighting factor; this method provides weights centered around the mean.19 The analyses were performed in SPSS v.21


Of the 21 007 individuals surveyed in the ENSE11, 6223 were women older than 50 years; 270 (4.3%) were excluded due to missing values, leaving 5953 for analysis. Their mean age was 66.4±11.4 years (range, 50-103 years). The number and percentage of women in each of the lifestyle and chronic CVD-related disease categories are shown in table 1, together with cumulative rates for CV mortality and mortality due to other causes. The estimated rate calculated for the 6 years of follow-up was 4% (n=239) for CV mortality and 7% (n=419) for mortality due to other causes. Mean age at death was 83.5±8.6 years for women who died of CVD and 78.6±10.8 years for those who died of another cause. Cumulative CV mortality and mortality due to other causes according to sociodemographic characteristics, other chronic diseases, self-rated health and quality of life, and use of health care services are shown in table 1 of the supplementary data. The mean EQ-5D-5L VAS score for self-rated health was 67.5±20.9 (50.3±21.9) for women who died of CVD and 52.2±23.0 for those who died of another cause.

Table 1.

Cumulative incidence of cardiovascular mortality and morbidity due to other causes according to lifestyle habits and chronic disease

  TotalAliveDied of cardiovascular diseaseDied of another cause 
  No.  No.  No.  No.  P 
Body mass index                  <.001 
Normal  1983  33.3  1814  91.5  54  2.7  115  5.8   
Overweight  1874  31.5  1713  91.4  56  3.0  105  5.6   
Obesity  1189  20.0  1060  89.1  49  4.1  80  6.8   
DK/DA  907  15.2  709  78.1  80  8.8  118  13.0   
Smoking                  <.001 
Never  4497  75.5  3897  86.6  227  5.0  374  8.3   
Exsmoker  693  11.6  663  95.7  1.3  21  3.0   
Smoker  763  12.8  735  96.5  0.4  24  3.1   
Exposure to environmental smoke                  <.001 
Never  5033  84.5  4426  87.9  220  4.4  387  7.7   
<1 h/d  370  6.2  346  93.4  10  2.6  15  3.9   
>1 h/d  550  9.2  523  95.2  1.7  17  3.1   
Alcohol                  <.001 
Does not drink  4231  71.1  3663  86.6  205  4.9  363  8.6   
Mean daily intake over a wk ≤20 g  1549  26.0  1464  94.5  32  2.1  53  3.4   
Mean daily intake over a wk ≤20 g  173  2.9  169  97.4  0.8  1.9   
Hours of sleep                  <.001 
>9 h/d  386  6.5  247  64.0  64  16.6  75  19.4   
7-9 h/d  3619  60.8  3324  91.8  105  2.9  191  5.3   
<7 h/d  1948  32.7  1725  88.6  70  3.6  153  7.8   
Main daily activity                  <.001 
Sitting most of the day  2339  39.3  1815  77.6  200  8.5  323  13.8   
Standing most of the day  3124  52.5  3002  96.1  36  1.2  86  2.7   
Walking-tasks involving exertion  490  8.2  478  97.6  0.5  1.9   
Physical activity during free time                  <.001 
Sedentary behavior  3025  50.8  2498  82.6  208  6.9  319  10.5   
Occasional activity  2358  39.6  2244  95.2  29  1.2  85  3.6   
Frequent activity  306  5.1  298  97.5  0.6  1.9   
Sports training  265  4.4  256  96.6  0.3  3.1   
Fruit consumption                  .229 
Daily  4591  77.1  4104  89.4  173  3.8  314  6.8   
> 3 times/wk  772  13.0  678  87.8  32  4.2  62  8.1   
1-2 times/wk  370  6.2  325  87.9  19  5.0  26  7.1   
<1 time/wk  219  3.7  188  86.0  15  6.7  16  7.3   
Consumption of vegetables                  <.001 
Daily  3366  56.5  3037  90.2  119  3.5  210  6.2   
> 3 times/wk  1906  32.0  1687  88.5  79  4.1  141  7.4   
1-2 times/wk  516  8.7  448  86.7  26  5.0  43  8.3   
<1 time/wk  164  2.8  124  75.5  15  9.1  25  15.4   
Consumption of pulses                  .004 
Daily  91  1.5  85  92.6  0.7  6.6   
> 3 times/wk  1383  23.2  1213  87.7  62  4.5  108  7.8   
1-2 times/wk  3608  60.6  3240  89.8  130  3.6  239  6.6   
<1 time/wk  698  11.7  620  88.8  31  4.4  47  6.7   
Never/almost never  172  2.9  138  80.2  15  8.8  19  11.0   
Consumption of dairy products                  .336 
Daily  5204  87.4  4630  89.0  208  4.0  365  7.0   
> 3 times/wk  340  5.7  304  89.4  17  4.9  20  5.8   
1-2 times/wk  159  2.7  147  92.4  1.6  10  6.0   
<1 time/wk  97  1.6  86  89.0  2.5  8.6   
Never/almost never  154  2.6  128  83.6  6.0  16  10.4   
Consumption of sweet products                  .009 
Daily  1607  27.0  1395  86.8  78  4.8  134  8.3   
> 3 times/wk  747  12.6  662  88.6  31  4.1  54  7.3   
1-2 times/wk  942  15.8  854  90.7  31  3.3  57  6.0   
<1 time/wk  1070  18.0  982  91.8  30  2.8  57  5.4   
Never/almost never  1586  26.6  1402  88.4  69  4.3  116  7.3   
Consumption of fast food                  <.001 
> 3 times/wk  76  1.3  68  88.7  3.3  8.0   
1-2 times/wk  357  6.0  330  92.3  1.6  22  6.1   
<1 time/wk  904  15.2  855  94.6  14  1.5  35  3.9   
Never/almost never  4615  77.5  4042  87.6  217  4.7  355  7.7   
Dental hygiene                  <.001 
≥ 3 times/d  2201  37.0  2067  93.9  51  2.3  83  3.7   
2 times/d  1985  33.3  1811  91.2  57  2.9  117  5.9   
1 time/d  1207  20.3  1030  85.3  63  5.3  114  9.4   
Never/occasionally  561  9.4  388  69.2  67  12.0  105  18.7   
Chronic disease                  <.001 
No  2016  33.9  1901  94.3  38  1.9  77  3.8   
Yes  3937  66.1  3395  86.2  201  5.1  342  8.7   
Hypertension                  <.001 
No  3438  57.7  3167  92.1  78  2.3  193  5.6   
Yes  2515  42.3  2129  84.6  161  6.4  225  9.0   
Acute myocardial infarction                  <.001 
No  5804  97.5  5194  89.5  218  3.8  392  6.8   
Yes  149  2.5  102  68.2  21  14.0  27  17.8   
Other heart diseases                  <.001 
No  5269  88.5  4794  91.0  147  2.8  328  6.2   
Yes  684  11.5  502  73.3  92  13.5  90  13.2   
Diabetes mellitus                  <.001 
No  5110  85.8  4640  90.8  162  3.2  308  6.0   
Yes  843  14.2  656  77.9  76  9.1  110  13.1   
High cholesterol                  .070 
No  3937  66.1  3483  88.5  157  4.0  298  7.6   
Yes  2016  33.9  1813  89.9  82  4.1  120  6.0   
Stroke                  <.001 
No  5835  98.0  5227  89.6  215  3.7  393  6.7   
Yes  118  2.0  68  58.0  24  20.4  25  21.5   

DK/DA, didn’t know/didn’t answer.

The results of the multivariate Cox model for CV mortality adjusted for competing causes of death and all the study variables analyzed are shown in table 2. The model was built using a random sample of 4204 women (71%) and tested in the remaining 1749 (29%). The HRs for CV mortality are shown for each item within the predictor categories. Sitting during most of the day vs walking around and performing tasks requiring exertion in the person's main daily activity was the strongest predictor of CV mortality (HR=2.757). This was followed by active smoking (HR=1.816) vs having never smoked, sleeping for more than 9hours a day (HR=1.809) vs 7 to 9hours, eating vegetables less than once a week (HR=1.758) vs every day, and having been admitted to hospital in the past year (HR=1.700). The only chronic diseases that independently predicted CV mortality were diabetes mellitus (HR=1.522) and high cholesterol. BMI did not have independent predictive power in the presence of the other factors. As seen in the last row of table 2, there was a significant interaction between age and mortality due to other causes, such that the HR represents the difference in the effect of age on CV mortality and mortality due to other causes. In brief, the risk of mortality due to other causes was 0.955 times that of CV mortality. In other words, age contributed to a slightly increased risk of CV mortality compared with mortality due to other causes. The model fit the data well (LRT=1072.6; P<.001), met the proportional hazards assumption (P=.257), and showed high predictive capacity in the validation sample, with a C index of 0.8407 (95%CI, 0.8025-0.8789).

Table 2.

Multivariate Cox model for cardiovascular mortality with adjustment for competing risks from other causes of death

  β  SE  HR (95%CI)  P 
Age, y  0.131  0.011  1.140 (1.116-1.165)  <.001 
EQ-5D-VAS  –0.012  0.003  0.988 (0.982-0.993)  <.001 
Body mass index
Overweight  –0.177  0.162  0.837 (0.61-1.15)  .275 
Obesity  0.011  0.174  1.011 (0.719-1.421)  .951 
DK/DA  0.097  0.149  1.102 (0.823-1.475)  .514 
Exsmoker  0.272  0.275  1.313 (0.766-2.251)  .321 
Smoker  0.597  0.280  1.816 (1.049-3.145)  .033 
Hours of sleep
7-9 h/d     
>9 h/d  0.593  0.157  1.809 (1.33-2.461)  <.001 
<7 h/d  0.235  0.121  1.265 (0.998-1.604)  .053 
Main daily activity
Walking around-tasks involving exertion     
Standing during most of the day  0.280  0.458  1.323 (0.539-3.245)  .542 
Sitting during most of the day  1.014  0.467  2.757 (1.104-6.885)  .030 
Vegetable consumption
> 3 times/wk  0.074  0.125  1.077 (0.843-1.376)  .551 
1-2 times/wk  0.073  0.186  1.076 (0.747-1.549)  .694 
< 1 time/wk  0.564  0.220  1.758 (1.143-2.707)  .010 
Diabetes mellitus
Yes  0.420  0.126  1.522 (1.189-1.949)  .001 
High cholesterol
Yes  –0.315  0.114  0.730 (0.584-0.912)  .006 
Hospital admission in past year
Yes  0.531  0.140  1.700 (1.292-2.237)  <.001 
Age*other causes  –0.046  0.012  0.955 (0.933-0.978)  <.001 

95%CI, 95% confidence interval; DK/DA, didn’t know/didn’t answer; EQ-5D-VAS, 5-level EQ-5D visual analog scale; HR, hazard ratio; SE, standard error.

Training sample, n=4204; cardiovascular deaths, n=177; deaths due to another cause, n=348; likelihood ratio test (χ2=1072.6; P<.001); C index=0.8656 (95%CI, 0.8472-0.8840); proportional hazards test, P=.257.

Validation in test sample (n=1749); “honest” C index=0.8407 (95%CI, 0.8025-0.8789).


Interaction with mortality due to other causes.

The results of the multivariate model were used to assign a score to each risk factor and build a CV risk scale for women based on their lifestyle habits and the presence of chronic diseases (table 3). BMI and high cholesterol levels were not included as they did not have independent predictive power in the multivariate analysis. The sum of scores for each predictor indicates the probability of CV mortality over 6 years (table 4). For example, an 85-year-old woman (5 points) who scored 80 on the EQ-5D-5L VAS (0 points), smoked (1 point), slept an average of 8hours a day (0 points), spent most of her day sitting (2 points), ate vegetables 3 times a week (0 points), did not have diabetes (0 points), and had been admitted to hospital once in the past year (1 point) would have a 33% risk of dying of CVD in the next 6 years (total score, 9 points). The curve showing the risk of CV mortality according to total score is shown in figure 1.

Table 3.

Risk scale for each category of predictor variables from the multivariate model

Risk factor  Category  Score 
Age, y  50-54  –2 
  55-59  –1 
EQ-5D-VAS (0-100)  0-24 
Smoking  Never smoked 
Sleep duration  9 h/d 
  >9 h/d 
Main daily activity  Walking-tasks involving exertion 
  Standing for most of the day 
  Sitting for most of the day 
Vegetable consumption  Daily 
  3 times/wk 
  1-2 times/wk 
  <1 time/wk 
Diabetes  No 
Hospital admission in past year  No 

EQ-5D-VAS, 5-level EQ-5D visual analog scale.

Table 4.

Probability of cardiovascular death over 6 years according to risk scale

Sum of points  Estimated risk (%) 
≤ 2  ≤ 0.4 
10  53.7 
11  77.3 
12  >94.0 
Figure 1.

Cumulative risk curve according to risk prediction scale scores.


We have shown that lifestyle habits are closely linked to CV mortality in women of menopausal age. Vegetable consumption, physical activity, smoking, and number of hours spent sleeping carried as much or more weight than chronic diseases or classic CV risk factors. We used our findings to design a simple 6-year CV risk scale based on self-reported data that had high predictive capacity.

Prevalence of CV risk factors

CV risk factors were common in the women studied: 42% had hypertension, 14% diabetes, and 34% high cholesterol. This indicates that there is much room for improvement in interventions aiming to promote heart-healthy diets, physical exercise, and avoidance of smoking or excessive alcohol intake. The proportion of women leading a sedentary life—51%—is similar to rates described in countries with different geographic, sociocultural, and economic backgrounds, such as Bangladesh (58%),20 India (55%),21 and Cameroon (51.9%).22


Numerous studies have analyzed the association between weight and CVD in postmenopausal women. It has been postulated that abdominal, not general, obesity is linked to insulin dependence and onset of diabetes and CVD,23 and one of the predisposing factors for centrally distributed obesity is early postmenopause. The combination of age, menopause, and abdominal obesity has been linked to the accumulation of classic CV risk factors such as hypertension, dyslipidemia, and diabetes.13 As in other settings such as heart failure, stroke, and atrial fibrillation, obesity defined by BMI exerts a protective effect against CVD.24,25


Dietary phytoestrogens, which are diphenolic components present at high levels in fruit and vegetables, have been shown to counter the antiestrogenic effects of postmenopause.26 Accordingly, they may be especially beneficial in populations such as ours. Basic research has identified a number of possible mechanisms underlying the beneficial effects of phytoestrogens, namely, affinity for estrogen receptors, antioxidant properties, and antiangiogenic and antiproliferative effects.27 Consumption of plant-based rather than animal-based protein has been shown to reduce low-density lipoprotein cholesterol and triglycerides.28 Unlike other strategies for reducing CV risk in postmenopausal women, eating vegetables has been shown to simultaneously reduce the risk of breast cancer.27 Vegetable consumption in our series was the strongest modifiable predictor of CV mortality and mortality due to other causes.

Physical activity

Physical activity has been shown to reduce CV risk in both the general population and postmenopausal women.29 Indeed, high levels of inactivity are thought to be one of the reasons why postmenopausal women have a higher CV risk than men.30 We were able to distinguish between women who engaged in physical activity for leisure and those whose main daily activity involved being physically active (regardless of whether or not this activity was considered to be work-related). Being active as part of one's main daily activity was closely associated with a lower risk of CV mortality, where leisure-time physical activity had no predictive capacity in the presence of other factors.

Although numerous studies have shown that nonoccupational physical activity reduces CV risk, very few studies have adjusted for physical activity performed as part of the person's main daily activity. We believe that this novel distinction is important, as work-related or similar physical activity occupies many more hours—and years—than leisure-time physical activity, which is typically performed for 30 to 120minutes a day 2 to 5 days a week. In our sample, the number of hours spent sitting or lying down was directly associated with CVD, supporting previous findings.14 Many of the studies showing the benefits of physical activity programs on CV risk in women have been conducted in sedentary, obese women,20 but the effect might be diluted in women who are very physically active in their daily routines. Cross-sectional studies analyzing the effects of physical activity in postmenopausal women have shown an inverse correlation between CVD risk and physical activity, with greater reductions observed with increasing activity.20 Leisure-time physical activity is obviously very important for sedentary women, but its effects are diluted in women whose daily routines involve being physically active.

Hours of sleep

Previous research has shown an association between CVD and excessive or deficient sleep,31 but none of the studies have specifically analyzed postmenopausal women. Although the causal associations between sleep duration and CVD are unclear, there are indications that genetic predisposition31 and concomitant risk factors such as dyslipidemia and insufficient physical activity32 may contribute to an increased CV risk. Predisposition to adverse coronary events has been shown in this setting.33

Nonsignificant classic CV risk factors in our population

High cholesterol, a known CV risk factor, exerted a protective effect in our cohort. We believe there are several reasons for this. Because our data were taken from a survey on lifestyle habits, we did not have access to lipid profiles, but a considerable proportion of the women diagnosed with high cholesterol were probably on treatment with statins, which have a strong protective role in CVD. There is also a close association between cholesterol levels and fruit and vegetable intake and physical activity, with basic research indicating that higher fruit and vegetable consumption reduces atherosclerosis linked to serum cholesterol levels.34 Because our results are based on self-reported data, the presence of hypercholesterolemia may be underestimated.

Lifestyle CV risk scale

CV risk scales have a dual purpose: to identify people with increased CV risk and to raise awareness among patients and health care professionals of the importance of adhering to treatments and encouraging action in this regard. Although current scales adjust for differences between men and women, the adjustments are exclusively quantitative in nature. Our risk scale, by contrast, is based on data from women of menopausal age, providing an easy-to-use scale directly applicable to postmenopausal women. A score of 6 points or more indicates a 5% increased risk in CV mortality but, as shown in figure 1, risk increases sharply after a score of 7. Age adds up to 2 points to the risk of premature CV death (before the age of 74 years). To maintain this risk under 5% thus, it is sufficient to refrain from smoking, take some physical activity every day, and eat plenty of vegetables.

Limitations and strengths

Our study has some limitations. Because of its retrospective, observational design, we cannot infer any causal relationships or rule out the presence of selection and exclusion biases. Although we controlled for confounders in our multivariate analysis, we cannot fully rule out the possibility of confounding. Likewise, some predictors of CV risk may be missing from our model. Our study also has some strengths, in particular the complex sampling design used, which provided representative estimates from a cohort of women older than 50 years living in Spain in 2011.


CV risk in women of menopausal age is significantly influenced by lifestyle habits. Factors such as vegetable consumption and physical activity are very important in this population. Other factors, however, such as high cholesterol and obesity, which are strong predictors in men, do not appear to have predictive value in postmenopausal women.


No funding was received for this study.

Authors’ contributions

J.A. Quesada, V. Bertomeu-González, J.M. Ruiz-Nodar, A. López-Pineda, and F. Sánchez-Ferrer contributed to the study design. J.A. Quesada requested the data and performed the statistical analyses. J.A. Quesada, V. Bertomeu-González, J.M. Ruiz-Nodar, A. López-Pineda, and F. Sánchez-Ferrer contributed to the interpretation of data. J.A. Quesada, V. Bertomeu-González, J.M. Ruiz-Nodar, A. López-Pineda, and F. Sánchez-Ferrer contributed to writing the manuscript. All the authors approved the final version of this manuscript.

Conflicts of interest



  • CVD is the leading cause of morbidity and mortality worldwide but there are marked differences between men and women. The prevalence of CV disease is lower in premenopausal women than in men of the same age but the opposite is true for postmenopausal women.

  • Many CV risk prediction models exist for the general population, but no studies have specifically analyzed predictors in postmenopausal women.


  • CV risk in postmenopausal age is significantly influenced by lifestyle habits. Vegetable consumption, physical activity, smoking, and number of hours spent sleeping carry as much or more weight than chronic diseases or classic CV risk factors. We have designed a simple 6-year CV risk scale based on self-reported data that has high predictive capacity.


Supplementary data associated with this article can be found in the online version available, at

Organización Mundial de la Salud (OMS). Cardiovascular diseases (CVDs). 2017. Available at: Accessed 27 Jul 2021.
M.F. Piepoli, A.W. Hoes, S. Agewall, et al.
2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).
Eur Heart J., 37 (2016), pp. 2315-2381
Y. Appelman, B.B. van Rijn, M.E. Ten Haaf, E. Boersma, S.A. Peters.
Sex differences in cardiovascular risk factors and disease prevention.
Atherosclerosis., 241 (2015), pp. 211-218
E.J. Benjamin, P. Muntner, A. Alonso, et al.
Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association.
Circulation., 139 (2019), pp. e56-e528
D. Zhu, H.F. Chung, A.J. Dobson, et al.
Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data.
Lancet Public Health., 4 (2019), pp. e553-e564
L. Mosca, A.H. Linfante, E.J. Benjamin, et al.
National study of physician awareness and adherence to cardiovascular disease prevention guidelines.
Circulation., 111 (2005), pp. 499-510
J.A. Damen, L. Hooft, E. Schuit, et al.
Prediction models for cardiovascular disease risk in the general population: systematic review.
BMJ., 353 (2016), pp. i2416
N.I. Parikh, R.P. Jeppson, J.S. Berger, et al.
Reproductive risk factors and coronary heart disease in the Women's Health Initiative observational study.
Circulation., 133 (2016), pp. 2149-2158
R.B. D’Agostino, M.W. Russell, D.M. Huse, et al.
Primary and subsequent coronary risk appraisal: new results from the Framingham study.
Am Heart J., 139 (2000), pp. 272-281
Y. Wang, A. O’Neil, Y. Jiao, et al.
Sex differences in the association between diabetes and risk of cardiovascular disease, cancer, and all-cause and cause-specific mortality: a systematic review and meta-analysis of 5,162,654 participants.
A. Ambikairajah, E. Walsh, N. Cherbuin.
Lipid profile differences during menopause: A review with meta-analysis.
Menopause., 26 (2019), pp. 1327-1333
R. Cifkova, J. Pitha, A. Krajcoviechova, E. Kralikova.
Is the impact of conventional risk factors the same in men and women? Plea for a more gender-specific approach.
Int J Cardiol., 286 (2019), pp. 214-219
C.J. Chang, C.H. Wu, W.J. Yao, Y.C. Yang, J.S. Wu, F.H. Lu.
Relationships of age, menopause and central obesity on cardiovascular disease risk factors in Chinese women.
Int J Obes Relat Metab Disord., 24 (2000), pp. 1699-1704
M.J. LaMonte, J.C. Larson, J.E. Manson, et al.
Association of sedentary time and incident heart failure hospitalization in postmenopausal women.
Circ Heart Fail., 13 (2020), pp. e007508
C. Álvarez-Dardet, J. Alonso, A. Domingo, et al.
La medición de la clase social en Ciencias de la Salud.
SG Editores, SEE, (1995),
H. Putter, M. Fiocco, R.B. Geskus.
Tutorial in biostatistics: competing risks and multi-state models.
Stat Med., 26 (2007), pp. 2389-2430
D.F. Moore.
Applied survival analysis using R.
Springer, (2016),
L.M. Sullivan, J.M. Massaro, R.B. D’Agostino Sr..
Presentation of multivariate data for clinical use: The Framingham Study risk score functions.
Stat Med., 23 (2004), pp. 1631-1660
M. Gómez-Beneyto, A. Nolasco, J. Moncho, et al.
Psychometric behaviour of the strengths and difficulties questionnaire (SDQ) in the Spanish national health survey 2006.
BMC Psychiatry., 13 (2013), pp. 95
L. Barua, M. Faruque, P. Chandra Banik, L. Ali.
Physical activity levels and associated cardiovascular disease risk factors among postmenopausal rural women of Bangladesh.
Indian Heart J., 70 (2018), pp. S161-S166
V.R. Tandon, A. Mahajan, S. Sharma, A. Sharma.
Prevalence of cardiovascular risk factors in postmenopausal women: A rural study.
J Midlife Health., 1 (2010), pp. 26-29
V.J. Ama Moor, J.R. Nansseu, M.E. Nouaga, et al.
Assessment of the 10-year risk of cardiovascular events among a group of Sub-Saharan African post-menopausal women.
Cardiol J., 23 (2016), pp. 123-131
N. Ozbey, E. Sencer, S. Molvalilar, Y. Orhan.
Body fat distribution and cardiovascular disease risk factors in pre- and postmenopausal obese women with similar BMI.
Endocr J., 49 (2002), pp. 503-509
L.M. Chiechi.
Dietary phytoestrogens in the prevention of long-term postmenopausal diseases.
Int J Gynaecol Obstet., 67 (1999), pp. 39-40
V. Bertomeu-Gonzalez, J. Moreno-Arribas, M.A. Esteve-Pastor, et al.
Association of body mass index with clinical outcomes in patients with atrial fibrillation: a report from the FANTASIIA Registry.
J Am Heart Assoc., 9 (2020), pp. e013789
Z.J. Wang, Y.J. Zhou, B.Z. Galper, F. Gao, R.W. Yeh, L. Mauri.
Association of body mass index with mortality and cardiovascular events for patients with coronary artery disease: a systematic review and meta-analysis.
Heart., 101 (2015), pp. 1631-1638
A. Cassidy.
Potential risks and benefits of phytoestrogen-rich diets.
Int J Vitam Nutr Res., 73 (2003), pp. 120-126
J.W. Anderson, B.M. Johnstone, M.E. Cook-Newell.
Meta-analysis of the effects of soy protein intake on serum lipids.
N Engl J Med., 333 (1995), pp. 276-282
E.J. Pekas, J. Shin, W.M. Son, R.J. Headid 3rd, S.Y. Park.
Habitual combined exercise protects against age-associated decline in vascular function and lipid profiles in elderly postmenopausal women.
Int J Environ Res Public Health., 17 (2020), pp. 3893
S.L. Gudmundsdottir, W.D. Flanders, L.B. Augestad.
Physical activity and cardiovascular risk factors at menopause: the Nord-Trøndelag health study.
Climacteric., 16 (2013), pp. 438-446
S. Ai, J. Zhang, G. Zhao, et al.
Causal associations of short and long sleep durations with 12 cardiovascular diseases: linear and nonlinear Mendelian randomization analyses in UK Biobank.
Z. Zhuang, M. Gao, R. Yang, et al.
Association of physical activity, sedentary behaviours and sleep duration with cardiovascular diseases and lipid profiles: a Mendelian randomization analysis.
Lipids Health Dis., 19 (2020), pp. 86
I. Daghlas, H.S. Dashti, J. Lane, et al.
Sleep duration and myocardial infarction.
J Am Coll Cardiol., 74 (2019), pp. 1304-1314
W. Guo, S.H. Kim, D. Wu, et al.
Dietary fruit and vegetable supplementation suppresses diet-induced atherosclerosis in LDL receptor knockout mice.
J Nutr., 151 (2021), pp. 902-910
Copyright © 2021. Sociedad Española de Cardiología
Revista Española de Cardiología (English Edition)

Subscribe to our newsletter

View newsletter history
Article options
Supplemental materials
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?